Characterization of a novel endoplasmic reticulum protein involved in tubercidin resistance in Leishmania major, PLoS Negl. Trop. Dis, vol.10, p.4972, 2016. ,
Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis, PLoS Negl. Trop. Dis, vol.6, p.1657, 2012. ,
Application of polymerase chain reaction with specific and arbitrary primers to identification and differentiation of Leishmania parasites, FEMS Microbiol. Lett, vol.114, pp.99-104, 1993. ,
Geographical sequence variation in the Leishmania major virulence factor P46, Infect. Genet. Evol, vol.30, pp.195-205, 2015. ,
, Biomarkers and surrogate endpoints: preferred definitions and conceptual framework, Biomarkers Definitions Working Group, vol.69, pp.89-95, 2001.
The heat shock protein HSP70 and heat shock cognate protein HSC70 contribute to antimony tolerance in the protozoan parasite Leishmania, Cell Stress Chaper, vol.9, pp.294-303, 2004. ,
Proteomic and genomic analyses of antimony resistant Leishmania infantum mutant, PLoS ONE, vol.8, p.81899, 2013. ,
Identification of a Leishmania infantum gene mediating resistance to miltefosine and SbIII, Int. J. Parasitol, vol.38, pp.1411-1423, 2008. ,
Functional cloning as a means to identify Leishmania genes involved in drug resistance, Mini Rev. Med. Chem, vol.6, pp.123-129, 2006. ,
Multiple mutations in heterogeneous miltefosineresistant Leishmania major population as determined by whole genome sequencing, PLoS Negl. Trop. Dis, vol.6, p.1512, 2012. ,
Isolation of genes mediating resistance to inhibitors of nucleoside and ergosterol metabolism in Leishmania by overexpression/selection, J. Biol. Chem, vol.274, pp.37723-37730, 1999. ,
Characterization of DNA sequences that confer complement resistance in Leishmania chagasi, Ann. N. Y. Acad. Sci, vol.1149, pp.347-351, 2008. ,
Genetic complementation to identify DNA elements that influence complement resistance in Leishmania chagasi, J. Parasitol, vol.91, pp.1058-1063, 2005. ,
Over-expression of cysteine leucine rich protein is related to SAG resistance in clinical isolates of Leishmania donovani, PLoS Negl. Trop. Dis, vol.9, p.3992, 2015. ,
Leishmania (Viannia) braziliensis transfectants overexpressing the miniexon gene lose virulence in vivo, Parasitol. Int, vol.58, pp.45-50, 2009. ,
Gene expression analysis of the mechanism of natural Sb(V) resistance in Leishmania donovani isolates from Nepal, Antimicrob. Agents Chemother, vol.49, pp.4616-4621, 2005. ,
Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background, PLoS Negl. Trop. Dis, vol.6, p.1514, 2012. ,
A specialized pathway affecting virulence glycoconjugates of Leishmania, Science, vol.269, pp.1869-1872, 1995. ,
Identification of genes encoding arabinosyltransferases (SCA) mediating developmental modifications of lipophosphoglycan required for sand fly transmission of Leishmania major, J. Biol. Chem, vol.278, pp.28840-28848, 2003. ,
Functional identification of galactosyltransferases (SCGs) required for species-specific modifications of the lipophosphoglycan adhesin controlling Leishmania major-sand fly interactions, J. Biol. Chem, vol.278, pp.15523-15531, 2003. ,
Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance, Genome Res, vol.21, pp.2143-2156, 2011. ,
Species-and strain-specific adaptation of the HSP70 super family in pathogenic trypanosomatids, Genome Biol. Evol, vol.8, 1980. ,
URL : https://hal.archives-ouvertes.fr/inserm-01342475
Modulation of aneuploidy in Leishmania donovani during adaptation to different in vitro and in vivo environments and its impact on gene expression, MBio, vol.8, pp.599-616, 2017. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01974269
Phenotypic diversity and selection maintain Leishmania amazonensis infectivity in BALB/c mouse model, Mem. Inst. Oswaldo Cruz, vol.112, pp.44-52, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01557855
Mini-exon gene variation in human pathogenic Leishmania species, 1994. ,
, Biochem. Parasitol, vol.66, pp.261-271
Growth cycledependent generation of complement-resistant Leishmania promastigotes, J. Immunol, vol.134, pp.2713-2718, 1985. ,
Cos-Seq for high-throughput identification of drug target and resistance mechanisms in the protozoan parasite Leishmania, Proc. Natl. Acad. Sci. U.S.A, vol.113, 2016. ,
A protein of the leucine-rich repeats (LRRs) superfamily is implicated in antimony resistance in Leishmania infantum amastigotes, Mol. Biochem. Parasitol, vol.158, pp.95-99, 2008. ,
Exploiting knowledge on Leishmania drug resistance to support the quest for new drugs, Trends Parasitol, vol.33, pp.162-174, 2017. ,
Leishmania donovani metacyclic promastigotes: transformation in vitro, lectin agglutination, complement resistance, and infectivity, Exp. Parasitol, vol.64, pp.147-156, 1987. ,
Analysis of genetic polymorphisms and tropism in East African Leishmania donovani by amplified fragment length polymorphism and kDNA minicircle sequencing, Infect. Genet. Evol, vol.65, pp.80-90, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01914735
Heterogeneity of molecular resistance patterns in antimony-resistant field isolates of Leishmania species from the western Mediterranean area, Antimicrob. Agents Chemother, vol.58, pp.4866-4874, 2014. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01060243
An approach to functional complementation by introduction of large DNA fragments into Trypanosoma cruzi and Leishmania donovani using a cosmid shuttle vector, Mol. Biochem. Parasitol, vol.65, pp.51-62, 1994. ,
A ricin agglutinin-resistant clone of Leishmania donovani deficient in lipophosphoglycan, Mol. Biochem. Parasitol, vol.28, pp.285-293, 1988. ,
Systematic review of biomarkers to monitor therapeutic response in leishmaniasis, Antimicrob. Agents Chemother, vol.59, pp.1-14, 2015. ,
Amplified fragment length polymorphism (AFLP) analysis is useful for distinguishing Leishmania species of visceral and cutaneous forms, Acta Trop, vol.113, pp.202-206, 2010. ,
Identification of genetic markers in sodium antimony gluconate (SAG) sensitive and resistant Indian clinical isolates of Leishmania donovani through amplified fragment length polymorphism (AFLP), Acta Trop, vol.110, pp.80-85, 2009. ,
Proteome mapping of overexpressed membrane-enriched and cytosolic proteins in sodium antimony gluconate (SAG) resistant clinical isolate of Leishmania donovani, Br. J. Clin. Pharmacol, vol.70, pp.609-617, 2010. ,
Increased transport of pteridines compensates for mutations in the high affinity folate transporter and contributes to methotrexate resistance in the protozoan parasite Leishmania tarentolae, EMBO J, vol.18, pp.2342-2351, 1999. ,
Plasticity of the Leishmania genome leading to gene copy number variations and drug resistance. F1000 Res, vol.5, p.2350, 2016. ,
Drug resistance analysis by next generation sequencing in Leishmania, Int. J. Parasitol. Drugs Drug Resist, vol.5, pp.26-35, 2015. ,
Gene expression modulation is associated with gene amplification, supernumerary chromosomes and chromosome loss in antimony-resistant Leishmania infantum, Nucleic Acids Res, vol.37, pp.1387-1399, 2009. ,
Genetic complementation of Leishmania deficient in PSA (GP46) restores their resistance to lysis by complement, Mol. Biochem. Parasitol, vol.137, pp.185-189, 2004. ,
Developmental modification of lipophosphoglycan during the differentiation of Leishmania major promastigotes to an infectious stage, EMBO J, vol.11, pp.3593-3600, 1992. ,
Characterization of natural antimony resistance in Leishmania donovani isolates, Am. J. Trop. Med. Hyg, vol.76, pp.681-688, 2007. ,
Screening and characterization of RAPD markers in viscerotropic Leishmania parasites, PLoS ONE, vol.9, 2014. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01077472
Genomic and molecular characterization of miltefosine resistance in Leishmania infantum strains with either natural or acquired resistance through experimental selection of intracellular amastigotes, PLoS ONE, vol.11, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01870304
Telomeric gene deletion and intrachromosomal amplification in antimony-resistant Leishmania, Mol. Microbiol, vol.88, pp.189-202, 2013. ,
Role of ABC transporter MRPA, gamma-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani, J. Antimicrob. Chemother, vol.59, pp.204-211, 2007. ,
Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells, Int. J. Parasitol, vol.41, pp.1311-1321, 2011. ,
A novel marker, ARM58, confers antimony resistance to Leishmania spp, Int. J. Parasitol. Drugs Drug Resist, vol.4, pp.37-47, 2014. ,
Leishmania AFLP: paving the way towards improved molecular assays and markers of diversity, Infect. Genet. Evol, vol.11, pp.960-967, 2011. ,
Polymerase chain reaction-miniexon: a promising diagnostic method for mucocutaneous leishmaniasis, Int. J. Dermatol, vol.55, pp.531-539, 2016. ,
Functional cloning of the miltefosine transporter. a novel P-type phospholipid translocase from Leishmania involved in drug resistance, J. Biol. Chem, vol.278, pp.49965-49971, 2003. ,
Drug resistance and treatment failure in leishmaniasis: a 21st century challenge, PLoS Negl. Trop. Dis, vol.11, p.6052, 2017. ,
Haplotype selection as an adaptive mechanism in the protozoan pathogen Leishmania donovani, Nat. Ecol. Evol, vol.1, pp.1961-1969, 2017. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02107201
Overexpression of a single Leishmania major gene enhances parasite infectivity in vivo and in vitro, Mol. Microbiol, vol.76, pp.1175-1190, 2010. ,
Spontaneous recovery of pathogenicity by Leishmania major hsp100/-alters the immune response in mice, Infect. Immun, vol.74, pp.6027-6036, 2006. ,
Chromosome and gene copy number variation allow major structural change between species and strains of Leishmania, Genome Res, vol.21, pp.2129-2142, 2011. ,
Shuttle cosmid vectors for the trypanosomatid parasite Leishmania, Gene, vol.131, pp.145-150, 1993. ,
Isolation of virulence genes directing surface glycosylphosphatidylinositol synthesis by functional complementation of Leishmania, Proc. Natl. Acad. Sci. U.S.A, vol.90, pp.8609-8613, 1993. ,
Leishmania-sand fly interactions controlling species-specific vector competence, Cell. Microbiol, vol.3, pp.189-196, 2001. ,
Developmental modification of the lipophosphoglycan from Leishmania major promastigotes during metacyclogenesis, Mol. Biochem. Parasitol, vol.42, pp.225-233, 1990. ,
Identification of an infective stage of Leishmania promastigotes, Science, vol.223, pp.1417-1419, 1984. ,
Identification and determination of the relationships of species and strains within the genus Leishmania using single primers in the polymerase chain reaction, Mol. Biochem. Parasitol, vol.77, pp.19-29, 1996. ,
Rapid diagnosis and genotyping of Leishmania isolates from cutaneous and visceral leishmaniasis by microcapillary cultivation and polymerase chain reaction-restriction fragment length polymorphism of miniexon region, Diagn. Microbiol. Infect. Dis, vol.53, pp.209-214, 2005. ,
In vitro selection of miltefosine resistance in promastigotes of Leishmania donovani from Nepal: genomic and metabolomic characterization, Mol. Microbiol, vol.99, pp.1134-1148, 2016. ,
Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major, Proc. Natl. Acad. Sci. U.S.A, vol.97, pp.9258-9263, 2000. ,
The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts, Proc. Natl. Acad. Sci. U.S.A, vol.100, pp.9536-9541, 2003. ,
Persistence without pathology in phosphoglycan-deficient Leishmania major, Science, vol.301, pp.1241-1243, 2003. ,
Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India, Parasit. Vectors, vol.10, p.49, 2017. ,
A telomeric cluster of antimony resistance genes on chromosome 34 of Leishmania infantum, Antimicrob. Agents Chemother, vol.60, pp.5262-5275, 2016. ,
Assessment of drug resistance related genes as candidate markers for treatment outcome prediction of cutaneous leishmaniasis in Brazil, Acta Trop, vol.126, pp.132-141, 2013. ,
Genome-wide stochastic adaptive DNA amplification at direct and inverted DNA repeats in the parasite Leishmania, PLoS Biol, vol.12, p.1001868, 2014. ,
Genetic markers for SSG resistance in Leishmania donovani and SSG treatment failure in visceral leishmaniasis patients of the Indian subcontinent, J. Infect. Dis, vol.206, pp.752-755, 2012. ,
In vivo selection for Leishmania donovani miniexon genes that increase virulence in Leishmania major, Mol. Microbiol, vol.54, pp.1051-1062, 2004. ,
Genetic analysis of Leishmania donovani tropism using a naturally attenuated cutaneous strain, PLoS Pathog, vol.10, p.1004244, 2014. ,
, Conflict of Interest Statement: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, 2018. ,